iShares Core MSCI Europe UCITS ETF EUR (Dist) (USD) | ISEURegister to Unlock Ratings |
Performance History | 31/08/2024 |
Growth of 1,000 (GBP) | Advanced Graph |
Fund | -6.1 | 26.8 | 2.0 | 9.6 | 9.2 | |
+/-Cat | -10.4 | 11.5 | 10.3 | -2.0 | 1.8 | |
+/-B’mrk | -8.7 | 9.2 | 6.6 | -3.6 | -0.1 | |
Category: Europe Large-Cap Blend Equity | ||||||
Category Benchmark: Morningstar DM Eur TME NR EUR |
Key Stats | ||
Closing Price 16/09/2024 | USD 35.65 | |
Day Change | -0.19% | |
Morningstar Category™ | Europe Large-Cap Blend Equity | |
Volume | 324034 | |
Exchange | LONDON STOCK EXCHANGE, THE | |
ISIN | IE00B1YZSC51 | |
Fund Size (Mil) 16/09/2024 | EUR 8065.43 | |
Share Class Size (Mil) 16/09/2024 | EUR 7805.26 | |
Ongoing Charge 26/01/2023 | 0.12% | |
*
This rating and report were issued for a different share class of this fund. The performance and fee structure of this class may vary from that referenced. |
Morningstar Research |
Investment Objective: iShares Core MSCI Europe UCITS ETF EUR (Dist) (USD) | ISEU |
The investment objective of this Fund is to provide investors with a total return, taking into account both capital and income returns, which reflects the return of the MSCI Europe Index. |
Returns | ||||||||||||||||
|
Management | ||
Manager Name Start Date | ||
Not Disclosed 06/07/2007 | ||
Inception Date 06/07/2007 |
Advertisement |
Category Benchmark | |
Fund Benchmark | Morningstar Benchmark |
MSCI Europe NR EUR | Morningstar DM Eur TME NR EUR |
Target Market | ||||||||||||||||||||
|
Portfolio Profile for iShares Core MSCI Europe UCITS ETF EUR (Dist) (USD) | ISEU | 12/09/2024 |
|
|
Top 5 Holdings | Sector | % |
Novo Nordisk AS Class B | Healthcare | 3.90 |
ASML Holding NV | Technology | 2.85 |
Nestle SA | Consumer Defensive | 2.41 |
AstraZeneca PLC | Healthcare | 2.19 |
SAP SE | Technology | 2.06 |
Increase Decrease New since last portfolio | ||
iShares Core MSCI Europe UCITS ETF EUR (Dist) (USD) | ISEU |